Zobrazeno 1 - 10
of 37
pro vyhledávání: '"R. B. Geller"'
Autor:
R B Geller
Publikováno v:
Journal of Clinical Oncology. 14:1371-1382
PURPOSE The colony-stimulating factors (CSFs) have been evaluated in patients with acute myelocytic leukemia (AML), both as potential priming agents and during and/or following induction chemotherapy to shorten the period of myelosuppression. The pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d60ca5574d2da8b321d832bf33049454
https://doi.org/10.1200/jco.1996.14.4.1371
https://doi.org/10.1200/jco.1996.14.4.1371
Autor:
Marianna Zahurak, Craig A. Hurwitz, R B Geller, Judith E. Karp, Curt I. Civin, Philip J. Burke, Steven Piantadosi
Publikováno v:
British Journal of Haematology. 76:340-347
A series of 23 monoclonal antibodies reactive with normal lymphoid and myeloid cells at various stages of differentiation were used to characterize 96 adult patients with acute myelocytic leukaemia (AML), concentrating on the possible role the expres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dbb6ef90b5012f0c17e07d69afad3c9
https://doi.org/10.1111/j.1365-2141.1990.tb06365.x
https://doi.org/10.1111/j.1365-2141.1990.tb06365.x
Autor:
Z. S. Pavletic, Abdul Hadi, Stefano R. Tarantolo, S. D. Day, Anne Kessinger, R. B. Geller, Shantaram S. Joshi, Joseph P. McGuirk, P. J. Bierman, James O. Armitage, James C. Lynch, Michael R. Bishop, Julie M. Vose, Sunil Abhyankar, James M. Foran, Robert G. Bociek
Publikováno v:
Cytotherapy. 5(6)
Immunological and clinical effects of post-transplant growth factor administration have not been well studied. This report describes the outcome and immune functions of a total of 50 HLA-matched related donor allogeneic blood stem-cell transplantatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca891440515d2a03617f41db127ab994
https://pubmed.ncbi.nlm.nih.gov/14660050
https://pubmed.ncbi.nlm.nih.gov/14660050
Autor:
M S, Tallman, P A, Rowlings, G, Milone, M J, Zhang, W S, Perez, D, Weisdorf, A, Keating, R P, Gale, R B, Geller, M J, Laughlin, H M, Lazarus, S M, Luger, P L, McCarthy, J M, Rowe, R A, Saez, M R, Vowels, M M, Horowitz
Publikováno v:
Blood. 96(4)
Allogeneic bone marrow transplantation is an effective postremission strategy for patients with acute myelogenous leukemia (AML) in first complete remission (CR). The value of administering consolidation chemotherapy before human leukocyte antigen (H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::02aee322baad9874723fdad77f03447a
https://pubmed.ncbi.nlm.nih.gov/10942365
https://pubmed.ncbi.nlm.nih.gov/10942365
Autor:
M R, Bishop, S R, Tarantolo, R B, Geller, J C, Lynch, P J, Bierman, Z S, Pavletic, J M, Vose, S, Kruse, S P, Dix, M E, Morris, J O, Armitage, A, Kessinger
Publikováno v:
Blood. 96(1)
Blood stem cell transplantation (BSCT) results in rapid hematopoietic recovery in both the allogeneic and autologous transplant settings. Because of the large numbers of progenitor cells in mobilized blood, the administration of growth factors after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6c60d6eedefefe30b0a0fb29c7f0fddc
https://pubmed.ncbi.nlm.nih.gov/10891434
https://pubmed.ncbi.nlm.nih.gov/10891434
Autor:
S P, Dix, R B, Geller
Publikováno v:
Oncology (Williston Park, N.Y.). 14(2)
Intensive outpatient care is rapidly becoming the primary mode of care for selected patients undergoing high-dose chemotherapy with autologous peripheral blood stem cell (PBSC) transplantation. Although the traditional inpatient model of care may sti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ceafefe62fff3e51a910f97166b547ab
https://pubmed.ncbi.nlm.nih.gov/10736807
https://pubmed.ncbi.nlm.nih.gov/10736807
Autor:
C Nichols, C F LeMaistre, A Smith, M Lange, J. E. Anderson, J M Fernandez Ranada, Julie M. Vose, W Longo, L. Garrison, E A Copelan, A Granena, A N Pandite, D L Topolsky, T Ahmed, R. B. Geller, I Tabbara, P. J. Bierman, Patrick J. Stiff, M W Schuster, R A Beveridge, M. E. Lebsack, A. Keating
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 15(4)
PURPOSE A phase III trial to compare PIXY321 with granulocyte-macrophage colony-stimulating factor (GM-CSF) following high-dose therapy and autologous bone marrow transplant (ABMT) was conducted to evaluate the time to hematopoietic recovery. PATIENT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8efccef669779463619c68ef961455b
https://pubmed.ncbi.nlm.nih.gov/9193361
https://pubmed.ncbi.nlm.nih.gov/9193361
Autor:
S M, Devine, R B, Geller, L B, Lin, S P, Dix, H K, Holland, D, Maurer, K, O'Toole, J, Keller, D G, Connaghan, L T, Heffner, C D, Hillyer, G E, Rodey, E F, Winton, R M, Maher, W E, Fitzsimmons, J R, Wingard
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 3(1)
Initial studies of FK506 combined with methotrexate (MTX) in patients receiving unrelated donor BMT have demonstrated a possible-decrease in the incidence of severe GVHD but high rates of severe stomatitis and nephrotoxicity. With this background, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f07f01e80e09f68944a1ef291470f32b
https://pubmed.ncbi.nlm.nih.gov/9209738
https://pubmed.ncbi.nlm.nih.gov/9209738
Autor:
S M, Devine, N J, Newman, J L, Siegel, G J, Joseph, T C, Geis, J A, Schneider, R B, Geller, J R, Wingard
Publikováno v:
Bone marrow transplantation. 18(3)
Three patients who developed acute onset of cerebral blindness within 5-47 days of BMT using tacrolimus (FK506) as primary GVHD prophylaxis are described. This syndrome has been described with the use of cyclosporin A (CsA) and FK506 in solid organ t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::39595f69a97a55e9d6309f32bb690825
https://pubmed.ncbi.nlm.nih.gov/8879619
https://pubmed.ncbi.nlm.nih.gov/8879619
Autor:
S P, Dix, J R, Wingard, R E, Mullins, I, Jerkunica, T G, Davidson, C E, Gilmore, R C, York, L S, Lin, S M, Devine, R B, Geller, L T, Heffner, C D, Hillyer, H K, Holland, E F, Winton, R, Saral
Publikováno v:
Bone marrow transplantation. 17(2)
Busulfan pharmacokinetics, specifically area under the concentration curve (AUC), have been correlated with the occurrence of veno-occlusive disease (VOD) following BMT. To evaluate the risk of VOD, we studied 66 patients who received pharmacotherape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7d718a994097ab2102244c95edb99b52
https://pubmed.ncbi.nlm.nih.gov/8640171
https://pubmed.ncbi.nlm.nih.gov/8640171